# TCG Crossover's Biotech Investments: 37 Startups in Its Portfolio (2026) > The 37 Biotech startups TCG Crossover has backed, by stage: $10B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/tcg-crossover-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 16 - [Abivax](https://millionrounds.com/company/abivax) - [Structure Therapeutics](https://millionrounds.com/company/structure-therapeutics) - [Mirum Pharmaceuticals](https://millionrounds.com/company/mirum-pharmaceuticals) - [Tyra Biosciences](https://millionrounds.com/company/tyra-biosciences) - [Avalo Therapeutics](https://millionrounds.com/company/avalo-therapeutics) - [Immunic Therapeutics](https://millionrounds.com/company/immunic-therapeutics) - [Century Therapeutics](https://millionrounds.com/company/century-therapeutics) - [Valneva](https://millionrounds.com/company/valneva) - [Rapt Therapeutics](https://millionrounds.com/company/rapt-therapeutics) - [CG Oncology](https://millionrounds.com/company/cg-oncology) - [Cogent Biosciences](https://millionrounds.com/company/cogent-biosciences) - [Tourmaline Bio](https://millionrounds.com/company/tourmaline-bio) - [VectivBio](https://millionrounds.com/company/vectivbio) - [Entrada Therapeutics](https://millionrounds.com/company/entrada-therapeutics) - [Athira Pharma](https://millionrounds.com/company/athira-pharma) - [AN2 Therapeutics](https://millionrounds.com/company/an2-therapeutics) ## Series C and later 12 - [ADC Therapeutics](https://millionrounds.com/company/adc-therapeutics) - [*ZL* Zai Lab](https://millionrounds.com/company/zai-lab) - [CORXEL Pharmaceuticals](https://millionrounds.com/company/corxel-pharmaceuticals) - [Beacon Therapeutics](https://millionrounds.com/company/beacon-therapeutics) - [ADCendo](https://millionrounds.com/company/adcendo) - [Aviceda Therapeutics](https://millionrounds.com/company/aviceda-therapeutics) - [Magenta Therapeutics](https://millionrounds.com/company/magenta-therapeutics) - [RayzeBio](https://millionrounds.com/company/rayzebio) - [Synthekine](https://millionrounds.com/company/synthekine) - [Plexium](https://millionrounds.com/company/plexium) - [*AB* Accro Bioscience](https://millionrounds.com/company/accro-bioscience) - [Affinia Therapeutics](https://millionrounds.com/company/affinia-therapeutics) ## Series B 5 - [*CT* Cidara Therapeutics](https://millionrounds.com/company/cidara-therapeutics) - [Mirador Therapeutics](https://millionrounds.com/company/mirador-therapeutics) - [Upstream Bio](https://millionrounds.com/company/upstream-bio) - [Alkeus Pharmaceuticals](https://millionrounds.com/company/alkeus-pharmaceuticals) - [Vicebio](https://millionrounds.com/company/vicebio) ## Series A 4 - [Disc Medicine](https://millionrounds.com/company/disc-medicine) - [Alpine Immune Sciences](https://millionrounds.com/company/alpine-immune-sciences) - [Vor Biopharma](https://millionrounds.com/company/vor-biopharma) - [Versanis Bio](https://millionrounds.com/company/versanis-bio) ## Segment by segment ### Stage not reported 16 startups · $5.7B raised - [**Abivax**](https://millionrounds.com/company/abivax) Abivax develops medicines that alter the body's natural immune system mechanisms. France $793M - [**Structure Therapeutics**](https://millionrounds.com/company/structure-therapeutics) Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR. United States $748M - [**Mirum Pharmaceuticals**](https://millionrounds.com/company/mirum-pharmaceuticals) Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies. United States $669M - [**Tyra Biosciences**](https://millionrounds.com/company/tyra-biosciences) Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs. United States $600M - [**Avalo Therapeutics**](https://millionrounds.com/company/avalo-therapeutics) Avalo Therapeutics is a clinical-stage biopharmaceutical company. United States $501M - [**Immunic Therapeutics**](https://millionrounds.com/company/immunic-therapeutics) Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies. United States $400M - [**Century Therapeutics**](https://millionrounds.com/company/century-therapeutics) Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies. United States $385M - [**Valneva**](https://millionrounds.com/company/valneva) Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases. France $310M ### Series C and later 12 startups · $2.5B raised - [**ADC Therapeutics**](https://millionrounds.com/company/adc-therapeutics) ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products. Switzerland $646M - [*ZL* **Zai Lab**](https://millionrounds.com/company/zai-lab) China $310M - [**CORXEL Pharmaceuticals**](https://millionrounds.com/company/corxel-pharmaceuticals) CORXEL Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2019, previously known as JiXing Pharmaceuticals. United States $287M - [**Beacon Therapeutics**](https://millionrounds.com/company/beacon-therapeutics) Beacon Therapeutics is a clinical-stage ophthalmic gene therapy company founded in 2023, dedicated to saving and restoring vision United States $247M - [**ADCendo**](https://millionrounds.com/company/adcendo) Adcendo ApS is a clinical-stage biotechnology company based in Frederiksberg, Copenhagen, Denmark, with operational offices in Bos Denmark $210M - [**Aviceda Therapeutics**](https://millionrounds.com/company/aviceda-therapeutics) Aviceda Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2018. United States $208M - [**Magenta Therapeutics**](https://millionrounds.com/company/magenta-therapeutics) Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. United States $187M - [**RayzeBio**](https://millionrounds.com/company/rayzebio) RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer. United States $160M ### Series B 5 startups · $1.2B raised - [*CT* **Cidara Therapeutics**](https://millionrounds.com/company/cidara-therapeutics) Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. United States $463M - [**Mirador Therapeutics**](https://millionrounds.com/company/mirador-therapeutics) Mirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California. United States $250M - [**Upstream Bio**](https://millionrounds.com/company/upstream-bio) Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. United States $200M - [**Alkeus Pharmaceuticals**](https://millionrounds.com/company/alkeus-pharmaceuticals) Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions. United States $150M - [**Vicebio**](https://millionrounds.com/company/vicebio) Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology. United Kingdom $100M ### Series A 4 startups · $661M raised - [**Disc Medicine**](https://millionrounds.com/company/disc-medicine) Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders. United States $275M - [**Alpine Immune Sciences**](https://millionrounds.com/company/alpine-immune-sciences) Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases. United States $199M - [**Vor Biopharma**](https://millionrounds.com/company/vor-biopharma) Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. United States $117M - [**Versanis Bio**](https://millionrounds.com/company/versanis-bio) Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults. United States $70M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names TCG Crossover as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with TCG Crossover** 27 co-investors](https://millionrounds.com/portfolio-maps/tcg-crossover-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **Sequoia Capital's AI portfolio** 209 startups · $543B](https://millionrounds.com/portfolio-maps/sequoia-capital-ai-portfolio) ## Raising from investors like TCG Crossover? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)